Finch Therapeutics Group Inc (FNCH:OTCMKTS)

$13.25 -0.11 (-0.82%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 72

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Finch Therapeutics Group Inc (FNCH:OTCMKTS) News Sources

North Down hospitality group Balloo Inns launch bid to expand Cyprus Avenue restaurant in east Belfast

The Irish News on MSN

external link

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion

The Economic Times

external link
FNCH stock
FNCH stock price
FNCH stock price today
FNCH stock prediction
FNCH earnings date
FNCH news
FNCH price
FNCH share
FNCH share price
FNCH shares
FNCH ceo
FNCH premarket
$FNCH
FNCH ticker
FNCH after hours
FNCH stock
FNCH stock price
FNCH stock price today
FNCH stock prediction
FNCH earnings date
FNCH news
FNCH price
FNCH share
FNCH share price
FNCH shares
FNCH ceo
FNCH premarket
$FNCH
FNCH ticker
FNCH after hours

Finch Therapeutics Group Inc (FNCH:OTCMKTS) FAQs

toggle

What is the current price of Finch Therapeutics Group Inc (FNCH:OTCMKTS)?

The current price of Finch Therapeutics Group Inc (FNCH:OTCMKTS) is $13.25.


toggle

Finch Therapeutics Group Inc (FNCH:OTCMKTS) absolute price change since previous trading day?

The absolute price change of Finch Therapeutics Group Inc (FNCH:OTCMKTS) since the previous trading day is $-0.11.


toggle

Finch Therapeutics Group Inc (FNCH:OTCMKTS) percentage price change since previous trading day?

The percentage price change of Finch Therapeutics Group Inc (FNCH:OTCMKTS) since the previous trading day is -0.82%.


toggle

What is This Week's average sentiment score for Finch Therapeutics Group Inc (FNCH:OTCMKTS)?

This Week's average sentiment score for Finch Therapeutics Group Inc (FNCH:OTCMKTS) is 72 out of 100.


toggle

What is This Week's average sentiment for Finch Therapeutics Group Inc (FNCH:OTCMKTS)?

This Week's sentiment for Finch Therapeutics Group Inc (FNCH:OTCMKTS) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.